America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
It's never too early to start thinking about retirement. Learn when and how to begin planning for a secure financial future.
13,704 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
When leaders sell stock alongside stronger earnings, investors should look beyond headlines. This guide breaks down i...
A fast acquittal may clear charges, but the financial fallout can linger for years. This guide explains how the phras...
A controlled study finds women face harsher judgments when AI helps craft resumes, while men's resumes win quicker ap...
A personal-finance reporter runs a controlled test with ChatGPT to draft a market update, revealing both efficiency g...
A working-class manager confronts a debt trap after purchasing a costly vehicle on a modest salary, underscoring how ...
Nebius stock all-time high sparked a flurry of questions. This guide breaks down the drivers, the risks, and a practi...
As AI-driven data centers swell, electricity bills could rise in parts of the U.S. Utilities may lean on natural gas ...
Through mid-May 2026, VXUS has risen about 10% year-to-date, narrowly surpassing the S&P 500’s roughly 8% gain. The m...
SpaceX is signaling a public debut that could rewrite IPO benchmarks, even as critics warn the proposed governance st...
Brent crude has surged aggressively since January, up about 85% by spring. This article breaks down what drove the mo...
The Janus Henderson AAA CLO ETF draws buyers with a high yield and AAA label, but a hidden tail-risk dynamic could er...